Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. (AVAH) is a leading provider of home healthcare services in the United States. Headquartered in Atlanta, Georgia, Aveanna Healthcare brings together two of the largest providers of pediatric care in the nation - Epic Health Services and PSA Healthcare. The company operates in 33 states with a rapidly growing network of over 200 branch offices. Aveanna Healthcare specializes in delivering comprehensive care to medically fragile patients, both children and adults, through its extensive range of services.
Core Services:
- Private Duty Services (PDS): This segment includes private duty nursing (PDN) and pediatric therapy services. The company provides highly skilled in-home nursing care, raising the standard for clinical expertise in the home care community.
- Home Health & Hospice (HHH): Aveanna offers adult home health and hospice services, providing a high-quality, lower-cost alternative to prolonged hospitalization.
- Medical Solutions (MS): This includes the delivery of enteral nutrition and other medical products to patients, ensuring they receive necessary medical supplies conveniently at home.
In addition to these core services, Aveanna Healthcare offers in-home aide services, respite care, school nurse services, rehabilitation, occupational therapy, and case management services. The company's goal is to provide a seamless healthcare experience by coordinating care among insurers, physicians, hospitals, and other healthcare providers.
Recent Achievements: Aveanna Healthcare has consistently expanded its operations due to overwhelming demand for quality care. The company has also been increasingly offering adult home care services, responding to the growing needs of the aging population.
Partnerships and Collaborations: Aveanna works closely with insurers, hospitals, and other healthcare providers to ensure comprehensive patient care. Its case management services play a crucial role in facilitating communication and coordination among different stakeholders in the healthcare system.
Financial Condition: Aveanna Healthcare derives its revenue primarily from pediatric healthcare services, adult home health and hospice services, and medical solutions. The company continues to focus on expanding its service offerings and improving its financial performance through strategic growth initiatives.
For the latest updates on Aveanna Healthcare Holdings Inc., including performance, events, and developments, please visit their Investor Relations section.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) will release its first quarter results on May 11, 2023, before market opening. A conference call is scheduled for 10:00 a.m. (ET) on the same day, allowing investors to engage with the company directly. Participants can access the live call at 1-877-407-0789 (US) or 1-201-689-8562 (international), with a replay available until May 18, 2023, using passcode 13737306. Aveanna provides a range of healthcare services across 33 states, including nursing, rehabilitation, and home health services, aimed at delivering quality care at lower costs compared to hospitalization. Interested parties can also join a live webcast via the company’s Investor Relations website.
Aveanna Healthcare Holdings (AVAH) reported Q4 2022 revenue of $451.1 million, up 9.0% from Q4 2021. Gross margin increased 3.5% to $128.8 million, but net loss widened to $237.8 million due to significant non-cash goodwill impairment charges. Adjusted EBITDA fell 35% to $29.7 million, marking 6.6% of revenue. For FY 2022, revenue rose 6.5% to $1.78 billion while net loss climbed to $662 million. The company forecasts revenue of at least $1.84 billion and adjusted EBITDA of at least $130 million for 2023, despite operational challenges.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) will announce its fourth quarter and full year results on March 16, 2023, before market open. A conference call will follow at 10 a.m. Eastern Time, where investors can join via phone or webcast. The replay will be available post-call until March 23, 2023. Aveanna provides diverse healthcare services across 33 states, including nursing and rehabilitation services for children and adults. The company aims to offer high-quality, cost-effective alternatives to prolonged hospital stays.
Aveanna Healthcare Holdings (NASDAQ: AVAH) announces the retirement of CEO Tony Strange, effective December 31, 2022. Jeff S. Shaner, the current COO, will take over as CEO. Tony's leadership was crucial for Aveanna's growth over the past five years, particularly during the pandemic. The company reaffirms its 2022 guidance of at least $1,782 million in revenue and $128 million in adjusted EBITDA, indicating stability despite leadership changes.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported Q3 2022 revenue of $443.0 million, a 7.7% increase from $411.3 million in Q3 2021, driven by Private Duty Services and Home Health & Hospice segments. However, gross margin decreased to 30.4% from 34.0% year-over-year. Net income rose to $24.3 million, with net income per diluted share at $0.13, but adjusted net loss per diluted share was $0.03. Full-year revenue guidance was revised down to $1,782 million, with Adjusted EBITDA expected at least $128 million, below previous guidance of $150 million.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced it will release its third quarter financial results on November 9, 2022, after market close. A conference call will follow on November 10, 2022, at 10:00 a.m. ET to discuss the results. Investors can join the call by dialing 1-877-407-0789 or access a webcast via the Investor Relations section of Aveanna's website. The replay of the call will be available until November 17, 2022. Aveanna provides a wide range of healthcare services across 33 states, focusing on quality care at lower costs.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported Q2 2022 revenue of $443 million, up from $436.1 million in Q2 2021, marking a 1.6% increase. However, the company faced significant challenges, including a net loss of $473.9 million compared to a net income of $1.3 million last year, primarily due to a $470.2 million goodwill impairment. Adjusted EBITDA decreased to $37 million, or 8.3% of revenue, down from 11.2% in Q2 2021. Aveanna remains optimistic about future growth opportunities despite ongoing labor market challenges and inflationary wage pressures.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced preliminary results for Q2 2022, indicating weaker performance due to ongoing labor market challenges and inflationary wage pressures. The company anticipates Adjusted EBITDA in the range of $36 million to $39 million, significantly lower than prior expectations. Revenue guidance has been revised down to at least $1,785 million, from an earlier estimate of $1,890 million to $1,920 million. Despite these challenges, Aveanna maintains liquidity with $12 million in cash and $167 million available under its revolving credit facility.
FAQ
What is the current stock price of Aveanna Healthcare Holdings (AVAH)?
What is the market cap of Aveanna Healthcare Holdings (AVAH)?
What services does Aveanna Healthcare provide?
Where is Aveanna Healthcare headquartered?
How many states does Aveanna operate in?
What is the main focus of Aveanna Healthcare's services?
Does Aveanna Healthcare offer services for adults?
What is included in Aveanna's Private Duty Services?
How does Aveanna Healthcare assist in care coordination?
What recent achievements has Aveanna Healthcare made?
What role does Aveanna play in the healthcare system?
Where can I find the latest news about Aveanna Healthcare?
